Purchases and Sales Made in Q2 2023 in Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR) during Q2 2023. The information is specifically focused on institutions that hold shares of Kymera Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 14, 2023
Q2 2023
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-137K- 49.41% |
$3.06M - $4.78M
|
140K
$6.33M
|
|
|
Aug 11, 2023
Q2 2023
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-159K- 83.94% |
$3.56M - $5.55M
|
30.4K
$1.37M
|
|
|
Aug 14, 2023
Q2 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-238KClosed |
$5.34M - $8.33M
|
0
$0
|
|
|
Aug 14, 2023
Q2 2023
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-358K- 18.17% |
$8.01M - $12.5M
|
1.61M
$72.8M
|
|
|
Aug 14, 2023
Q2 2023
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-542K- 22.49% |
$12.1M - $18.9M
|
1.87M
$84.4M
|